Reemo Health, Inc.

Reemo Health, Inc. is a health technology company focused on enhancing healthcare engagement through innovative solutions, including their flagship smartwatch designed for at-risk populations. Founded in 2014 and headquartered in Minneapolis, US, Reemo Health, Inc. offers health technology solutions that empower users to manage their health more effectively.

The company has raised USD 0. 6 mn in funding from Jumpstart Health Investors as of May 31, 2018. Rain Saal serves as the Founder, having previously founded other ventures, while John Valiton is the current CEO. Reemo specializes in innovative health technology, primarily through its flagship product, the Reemo Health Smartwatch, designed to enhance healthcare engagement for at-risk populations.

The smartwatch enables users to monitor their health metrics, facilitating real-time data collection and communication with healthcare providers. This product supports individuals in taking ownership of their health while streamlining care delivery, reducing the burden of in-person visits. The target user base includes aging seniors and individuals utilizing Medicaid, with distributions primarily across the United States, focusing on markets that require effective management of chronic conditions and a holistic approach to patient care. Reemo generates revenue through a subscription-based model, wherein healthcare organizations partner with the company to provide the Reemo Health Smartwatch to their members.

Clients, including health plans and organizations serving Medicaid populations, integrate the smartwatch into their care programs to enhance patient engagement and operational efficiency. Transactions typically involve annual subscriptions that cover the smartwatch's use and associated support services, leveraging actionable insights from user data to meet regulatory standards such as STARS and HEDIS, while ensuring sustained member enrollment and retention. Pricing plans are tailored to meet the needs of clients, maximizing value for providers and end users. Reemo Health, Inc.

plans to leverage its recent funding of USD 0. 6 mn from May 2018 to support upcoming developments and market expansion. The company is focused on designing new product features to enhance the functionality of the Reemo Health Smartwatch, with planned releases expected in 2024. Additionally, Reemo aims to expand its reach beyond the current U.

S. market into regions with significant Medicaid populations, targeting states like California and New York for growth by the end of 2025.